Skip to main content

Table 1 Survival status of resected NSCLC patients according to La mRNA expression levels

From: The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®

La expression (compared to healthy tissue) Survival status Number per group
  Dead Alive  
>2-fold increase 103 (61%) 65 (39%) 168
<2-fold increase 133 (48%) 142 (52%) 275
  1. The mRNA expression of La and survival status of patients with resected NSCLC was examined using Oncomine, with data originally derived from[27].